ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
<p><strong>Objectives</strong></p> <p>The use of aspirin for the secondary prevention of cardiovascular disease (CVD) is firmly established, and the proportional reductions in heart attacks and strokes appear to be similar in people with and without diabetes. Uncertaint...
Հիմնական հեղինակներ: | Bowman, L, Mafham, M, Stevens, W, Haynes, R, Buck, G, Collins, R, Armitage, J, ASCEND Study Collaborative Group |
---|---|
Ձևաչափ: | Journal article |
Հրապարակվել է: |
Elsevier
2017
|
Նմանատիպ նյութեր
-
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
: Parish, S, և այլն
Հրապարակվել է: (2022) -
Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
: Emily L. Sammons, և այլն
Հրապարակվել է: (2024-11-01) -
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
: Sarah Parish, և այլն
Հրապարակվել է: (2023-03-01) -
ASCEND-Eye: effects of aspirin on diabetic retinopathy
: Sammons, E, և այլն
Հրապարակվել է: (2024) -
ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy
: Sammons, E, և այլն
Հրապարակվել է: (2023)